Barty Medical

Name

Barty Medical

Legal name

巴泰医疗科技（浙江）股份有限公司

Website

https://bartymedical.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Vascular Interventional Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

• Vascular interventional devices
• Drug-coated balloons
• PTCA balloon catheters
• Constrained balloon technology
• Peripheral vascular intervention

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Vascular Interventional Medical Device Sales: Barty Medical generates revenue primarily through the sale of proprietary vascular interventional medical devices, including coronary drug-coated balloons, peripheral drug-coated balloons, coronary PTCA balloons, peripheral PTA balloons, peripheral drug-eluting stents, and配套导管鞘、造影导管、导引导管. Revenue streams include domestic hospital sales, distributor sales, and international export sales to over 40 countries.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Barty Medical is a Hangzhou-based medical device manufacturer that develops, produces, and sells vascular interventional devices, including coronary and peripheral drug-coated balloons, PTCA/PTA balloon dilation catheters, guiding catheters, angiographic catheters, introducer sheaths, and a thrombus aspiration system. The company serves hospital vascular surgery and cardiology departments with proprietary constrained-balloon and excipient-free nano-needle drug coating platforms.

Product overview

巴泰医疗是一家致力于血管介入领域医疗器械研发、制造、销售的国家级高新技术企业，业务线主要覆盖心血管介入和外周介入两大领域。公司已形成完整的血管介入解决方案，包括血管通路产品（导管鞘、造影导管、导引导管）、管腔准备产品（普通球囊、约束型球囊）、"介入无植入"药物治疗产品（药物球囊、约束型药物球囊）以及血栓抽吸系统。心血管介入产品包括：凤泰® Flowty®冠脉药物球囊、鹂泰泰®系列PTCA球囊扩张导管、鹭泰®造影导管、鲤泰®导引导管、鹤泰®HEETY®导管鞘组。外周血管介入产品包括：Matrix Super®/Matrix Super®PTX约束型球囊系列、鹰泰®药物球囊、凰泰®/Ultra凰泰®系列PTA球囊、鹤泰®HEETY®导管鞘组、血栓抽吸系统。公司目前拥有19款NMPA三类注册证、8项欧盟CE证书，已远销40多个国家和地区。

Differentiator

Problem solved

Functional benefit

Brands

• 凤泰（Flowty）: 紫杉醇洗脱PTCA球囊扩张导管，用于心血管介入治疗，国家创新医疗器械特别审批产品。
• 鹰泰
• Matrix Super
• 鹤泰（HEETY）
• 鲤泰
• 凰泰
• Ultra 鹂泰
• 鹂泰
• 鹂泰PRO
• Ultra 鹂泰PRO
• Matrix Super PTX
• Ultra凰泰II代
• 鹭泰
• Ultra凰泰
• Ultra凰泰II代（0.018英寸系统）

Products and services

• Flowty® Paclitaxel-Eluting PTCA Balloon Dilation Catheter (凤泰) Coronary drug-coated balloon catheter featuring a new-generation excipient-free nano-needle drug coating design, used for interventional treatment of coronary artery stenosis or occlusion. Targeted at interventional cardiologists and tertiary hospital cardiology departments.
• Matrix Super® Peripheral Constrained Balloon (Matrix Super 外周约束型球囊) Peripheral constrained balloon dilation catheter with embedded nitinol memory alloy metal mesh that constrains the balloon during inflation, enabling controlled, uniform, non-traumatic vessel expansion while reducing flow-limiting dissections. Used by vascular surgeons for peripheral arterial disease treatment.
• Yingty® Paclitaxel-Coated Peripheral Balloon Dilation Catheter (鹰泰) Peripheral drug-coated balloon catheter with pure paclitaxel excipient-free nano-needle crystalline coating for sustained drug delivery during peripheral vascular interventional procedures. Targets vascular surgeons treating peripheral arterial disease.
• Matrix Super PTX® Peripheral Constrained Drug-Coated Balloon (Matrix Super PTX) Peripheral constrained drug-coated balloon catheter combining nitinol memory alloy mesh-constrained balloon platform with paclitaxel drug coating; performs vessel preparation and drug treatment in a single step, significantly reducing rescue stent implantation rates. Used by vascular surgeons treating peripheral arterial disease.
• Ultra Huangty® II Gen Peripheral Double-Layer High-Pressure Balloon Catheter (Ultra 凰泰II代) Peripheral high-pressure balloon dilation catheter with dual-layer construction, available in both 0.018" and 0.035" guidewire systems; rated burst pressure up to 26atm for challenging peripheral lesion preparation.
• Huangty® PTA Balloon Dilation Catheter (凰泰) Peripheral transluminal angioplasty (PTA) balloon dilation catheter with ultra-fine tapered tip design offering superior crossability, compatible with 14, 18, and 35 guidewire systems for peripheral vascular lesion treatment.
• Litai® PRO PTCA Balloon Dilation Catheter (鸷泰PRO) Coronary PTCA balloon dilation catheter for coronary artery dilation in interventional cardiology procedures. Performance-upgraded version targeting tertiary hospital cardiology departments.
• Heety® Single-Use Introducer Sheath Group (鹤泰 HEETY 桡鞘) Single-use introducer sheath group for radial artery access establishment in cardiovascular interventional procedures. According to industry data, ranked #1 among domestic sheath brands and #2 in the overall China market by 2025 revenue.
• Thrombus Aspiration System (血栓抽吸系统) Medical device used for peripheral vascular thrombus aspiration treatment, approved by NMPA in November 2024. Targeted at vascular surgeons performing peripheral interventions for acute or subacute thrombosis.
• OEM Manufacturing Services Contract manufacturing services providing OEM production of vascular interventional medical devices for other medical device companies seeking quality manufacturing partners.

Quantifiable outcome

• Matrix Super PTX外周约束型药物球囊于2024年7月获批上市，是全球第二、中国首款第三代血管介入球囊产品
• +5 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators12 records

Recent moves1 record

Expansion highlights6 records

Broad incumbents

• Boston Scientific: Global interventional leader with Ranger DCB, Lutonix, Eluvia DES and a wide peripheral vascular portfolio. Benchmark competitor to Barty's constrained DCB/PTA pipeline and reference partner in any premium-tier Chinese hospital VBP negotiations.
• MicroPort Scientific: Hong Kong-listed Chinese interventional cardiology and peripheral device conglomerate (MicroPort NeuroTech, Endovastec, etc.). Wide product breadth across coronary, peripheral and structural heart gives it scale advantages over the comparatively focused Barty portfolio.
• Lepu Medical: Beijing-based broad cardiovascular device and IVD player with coronary stents and DCBs. Operates across the same Chinese tertiary hospital channels as Barty but with a much broader portfolio and established brand.
• Medtronic: Global interventional incumbent with category-defining IN.PACT Admiral DCB in peripheral vascular and strong presence in China. Sets the dominant benchmark Barty's Matrix Super PTX competes against in domestic and (post-EU MDR) international markets.
• Terumo: Japan-headquartered global peripheral and coronary interventional device player (peripheral DCB systems, guiding catheters, sheaths). Directly comparable in catheter sheath and guide catheter SKUs to Barty's Heety guiding-catheter-sheath line (#2 China-wide by 2025 revenue).

Direct peers

• Acotec Scientific: Beijing/Hong Kong-listed Chinese peripheral interventional device company with a leading DCB product line (e.g., AcoArt Orchestra) and peripheral balloon franchise. Directly comparable to Barty's peripheral constrained DCB and PTA portfolio and serves the same Chinese vascular surgery customer base.
• JW Medical Systems (OrbusNeich): Hong Kong-listed interventional cardiology and peripheral device company (OrbusNeich parent) producing balloons, scoring balloons and DCBs used by vascular surgeons and interventional cardiologists. Highly comparable product overlap with Barty's coronary and peripheral balloon SKUs.
• Concept Medical Inc: Specialist drug-coated balloon innovator (MagicTouch sirolimus-coated balloon) with global multi-center trials. Closest pure-play DCB technology peer to Barty's excipient-free nano-needle coating platform and constrained DCB roadmap.

Emerging players

• iVascular: Barcelona-based emerging DCB and peripheral interventional specialist with a pan-European footprint. Comparable peripheral DCB/angioplasty device portfolio serving vascular surgery and overlaps with Barty's international (EU/EMEA) expansion target markets.
• Sahajanand Medical Technologies (SMT): Indian-headquartered emerging interventional device and DCB player expanding across emerging markets. Operates in overlapping emerging-market geographies to Barty's Southeast Asia/Latin America export targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/bartymedical
• YouTubeyoutube.com/bartymedical
• Facebookfacebook.com/catheterballoon
• LinkedInlinkedin.com/company/zhejiang-barty-medical-technology-co-ltd

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barty Medical